Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00198263 · ClinicalTrials.gov registry record · Phase 4

Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer

A Phase 4 study, sponsored by Inovio Pharmaceuticals.

Completed
Registry status
Phase 4
Development phase
95
Enrollment target

NCT00198263: Completed Phase 4 study, sponsored by Inovio Pharmaceuticals.

NCT00198263 is a Phase 4 study that has completed, run by Inovio Pharmaceuticals. The registered enrollment target is 95 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00198263, a Phase 4 study, has completed, sponsored by Inovio Pharmaceuticals.

COMPLETED
Registry status
Phase 4
Development phase
95 participants
Enrollment target

Study Summary

The purpose of the trial is to study the safety and efficacy of the Medpulser Electroporation System with bleomycin in the treatment of head and neck cancer.

Interventions

  • COMBINATION_PRODUCT Medpulser Electroporation with Bleomycin

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2004-01
Est. Completion 2008-09
Phase Phase 4
Inovio Pharmaceuticals

28 total trials

What the finished NCT00198263 record still lists

NCT00198263 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 1 intervention - of which Medpulser Electroporation with Bleomycin is the first listed.

NCT00198263 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00198263 about?

NCT00198263 is a clinical study titled "Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer". The purpose of the trial is to study the safety and efficacy of the Medpulser Electroporation System with bleomycin in the treatment of head and neck cancer.

What is the current status of trial NCT00198263?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 95 participants. The study started on 2004-01. Estimated completion is 2008-09.

What interventions are being tested in trial NCT00198263?

The interventions under investigation include: Medpulser Electroporation with Bleomycin (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT00198263?

This trial is sponsored by Inovio Pharmaceuticals, which has 28 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00198263's enrollment target sits among peer trials

95 869th of 2000 higher than 1,130 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00198263, the US trial registry maintained by the National Library of Medicine. NCT00198263 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.